168 related articles for article (PubMed ID: 18751724)
1. Unusually severe phenotype of neonatal primary hyperparathyroidism due to a heterozygous inactivating mutation in the CASR gene.
Obermannova B; Banghova K; Sumník Z; Dvorakova HM; Betka J; Fencl F; Kolouskova S; Cinek O; Lebl J
Eur J Pediatr; 2009 May; 168(5):569-73. PubMed ID: 18751724
[TBL] [Abstract][Full Text] [Related]
2. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
[TBL] [Abstract][Full Text] [Related]
3. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
[TBL] [Abstract][Full Text] [Related]
5. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
[TBL] [Abstract][Full Text] [Related]
6. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy.
Waller S; Kurzawinski T; Spitz L; Thakker R; Cranston T; Pearce S; Cheetham T; van't Hoff WG
Eur J Pediatr; 2004 Oct; 163(10):589-94. PubMed ID: 15241688
[TBL] [Abstract][Full Text] [Related]
7. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.
Reh CM; Hendy GN; Cole DE; Jeandron DD
J Clin Endocrinol Metab; 2011 Apr; 96(4):E707-12. PubMed ID: 21289269
[TBL] [Abstract][Full Text] [Related]
8. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.
Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM
Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.
Gannon AW; Monk HM; Levine MA
J Clin Endocrinol Metab; 2014 Jan; 99(1):7-11. PubMed ID: 24203066
[TBL] [Abstract][Full Text] [Related]
10. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
[TBL] [Abstract][Full Text] [Related]
11. A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
Szczawinska D; Schnabel D; Letz S; Schöfl C
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1146-53. PubMed ID: 24517148
[TBL] [Abstract][Full Text] [Related]
12. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
Watanabe S; Fukumoto S
Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene.
Özgüç Çömlek F; Demir S; Gürkan H; İnan M; Sezer A; Dilek E; Kökenli F
Pediatr Endocrinol Diabetes Metab; 2022; 28(2):168-174. PubMed ID: 35399047
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
Bai M; Pearce SH; Kifor O; Trivedi S; Stauffer UG; Thakker RV; Brown EM; Steinmann B
J Clin Invest; 1997 Jan; 99(1):88-96. PubMed ID: 9011580
[TBL] [Abstract][Full Text] [Related]
15. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene.
Cole DE; Janicic N; Salisbury SR; Hendy GN
Am J Med Genet; 1997 Aug; 71(2):202-10. PubMed ID: 9217223
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
[TBL] [Abstract][Full Text] [Related]
17. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.
Marx SJ; Sinaii N
J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168
[TBL] [Abstract][Full Text] [Related]
18. Unusual case of neonatal hypercalcemia.
Brickman TM; Stark MW; Jeyakumar A
Int J Pediatr Otorhinolaryngol; 2015 May; 79(5):758-9. PubMed ID: 25792032
[TBL] [Abstract][Full Text] [Related]
19. Neonatal severe hyperparathyroidism due to compound heterozygous mutation of calcium sensing receptor (CaSR) gene presenting as encephalopathy.
Kulkarni A; Mohite M; Vijaykumar R; Bansode P; Murade S; Tamhankar PM
Indian J Pediatr; 2014 Nov; 81(11):1228-9. PubMed ID: 24763815
[TBL] [Abstract][Full Text] [Related]
20. A Case of a Heterozygous Inactivating CASR Variant with Adult-Onset Symptomatic Hypercalcemia Requiring Extensive Surgery.
Veldeman L; Robbrecht S; Breckpot J; Weynand B; Decallonne B
Calcif Tissue Int; 2020 Jul; 107(1):104-108. PubMed ID: 32306059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
